Menon Pistons Limited (MENNPIS) — +26.01% Price Surge

25 June 2026 · MENNPIS · Results Analysis

Market Analysis: Top Performers in Indian Equity Markets (June 24, 2026)

Here is the detailed analysis of the top-performing stocks in the Indian equity markets based on recent price action and fundamentals:

1. Menon Pistons Limited (MENNPIS)

  • Sector: Automobile & Auto Components
  • Industry: Auto Components
  • Current Price: ₹71.33
  • Market Cap: ₹309.21 Cr
  • Performance: +26.01%
  • Technical Indicators:
  • - RSI(14): 83.64 (Overbought)

    - SMA 50: ₹57.75

  • Key Drivers:
  • - Strong momentum in the auto components sector.

    - Overbought RSI suggests potential short-term consolidation but underlying bullishness remains.

    2. Black Rose Industries Ltd (BLACKROSE)

  • Sector: Chemicals
  • Industry: Chemicals & Petrochemicals
  • Current Price: ₹122.52
  • Market Cap: ₹491.13 Cr
  • Performance: +25.75%
  • Technical Indicators:
  • - RSI(14): 83.41 (Overbought)

    - SMA 50: ₹94.43

  • Recent Developments:
  • - Q4 FY26 Results: Revenue up 38%, EBITDA growth over 90%.

    - Declared a dividend of 125% for the last financial year.

    - Remains debt-free, enhancing financial stability .

  • Valuation Concerns:
  • - P/E Ratio: 27.87

    - Market cap expanded to ₹624.95 Cr as of June 23, 2026 .

    3. EMS Limited (EMSLIMITED)

  • Sector: Utilities
  • Industry: Other Utilities
  • Current Price: ₹445.60
  • Market Cap: ₹1,802.81 Cr
  • Performance: +25.02%
  • Fundamentals:
  • - Order Book: ₹1,837 Cr as of March 31, 2026.

    - FY27 Revenue Target: ₹1,000 Cr (indicating recovery).

    - Long-term CAGR growth target of 20-25% .

  • Technical Setup:
  • - Trading above all major moving averages (5D, 20D, 50D, 100D, 200D).

    - Strong volume surge and institutional participation .

  • Risks:
  • - Recent results showed a 55.34% decline in revenue and 88% drop in net profit for Q4 FY26 .

    4. Kirloskar Oil Engines Limited (KIRLOSENG)

  • Sector: Capital Goods
  • Industry: Industrial Products
  • Current Price: ₹2,504.40
  • Market Cap: ₹25,295.41 Cr
  • Performance: +24.40%
  • Recent Catalyst:
  • - Secured a 192 MW data centre order from HyperNext, marking a major entry into the hyperscale data centre space dominated by Cummins .

  • Financial Highlights:
  • - Q3 FY25: Revenue ₹1,453.70 Cr, Profit ₹67.89 Cr.

    - capex commitment: ₹1,400 Cr for expanding Kagal factory capacity by 20,000 engines/year .

  • Valuation:
  • - P/E Ratio: 49.81

    - Stock has delivered multibagger returns (183% in 1 year, 879% in 5 years) .

    5. SPCenet (Not enough data available)

    6. Themis Medicare (THEMISMED)

  • Sector: Healthcare
  • Performance: +18.60%
  • Observations:
  • - Strong performance likely driven by sector tailwinds and possibly recent contract wins or product launches.

    - Further fundamental details required for deeper analysis.

    7. NOCIL (NOCIL)

  • Sector: Chemicals
  • Performance: +18.53%
  • Observations:
  • - Likely benefiting from firm commodity prices and strong demand in the specialty chemicals space.

    - Detailed financials not provided; monitor for earnings momentum.

    8. Mohit Industries (MOHITIND)

  • Sector: Textiles
  • Performance: +17.98%
  • Observations:
  • - Textile sector seeing revival due to domestic and export demand.

    - Check for recent order bookings or margin expansion.

    9. Orient Hotel (ORIENTHOT)

  • Sector: Hospitality
  • Performance: +16.33%
  • Observations:
  • - Possible rebound from pandemic-related lows.

    - Look for occupancy rates and revenue per available room (RevPAR) trends.

    10. Kotyark Industries Limited (KOTYARK)

  • Sector: Oil & Gas
  • Industry: Petroleum Products
  • Current Price: ₹453.80
  • Market Cap: ₹459.73 Cr
  • Performance: +16.16%
  • Technical Indicators:
  • - RSI(14): 69.87

    - SMA 50: ₹421.37

  • Key Notes:
  • - Benefiting from rising oil prices and possibly strong refining margins.

    - Promoter holding remains at 0% .

    Summary Table

    StockSectorPerformanceCurrent Price (₹)Market Cap (₹ Cr)Key Driver
    MENNPISAuto Components+26.01%71.33309.21Auto sector momentum
    BLACKROSEChemicals+25.75%122.52491.13Strong Q4 FY26 results, dividend
    EMSLIMITEDUtilities+25.02%445.601,802.81Large order book, institutional buying
    KIRLOSENGIndustrial Products+24.40%2,504.4025,295.41192 MW data centre order from HyperNext
    SPCENET+20.68%Data not available
    THEMISMEDHealthcare+18.60%Sector tailwinds
    NOCILChemicals+18.53%Commodity price firming
    MOHITINDTextiles+17.98%Domestic & export demand revival
    ORIENTHOTHospitality+16.33%Post-pandemic recovery
    KOTYARKPetroleum Products+16.16%453.80459.73Rising oil prices
    Note: For stocks like SPCENET, THEMISMED, NOCIL, MOHITIND, and ORIENTHOT, detailed fundamental data was not provided. Further investigation into earnings, order wins, and sector trends is recommended.

    Peer Comparison (Selected Stocks)

    MetricBLACKROSEEMSLIMITEDKIRLOSENGMENNPIS
    P/E Ratio27.8721.9649.81
    Market Cap (Cr)624.952,483.0625,295.41309.21
    Dividend Yield0.43%
    RSI (14)83.4160.5383.64
    SMA 50 (₹)94.43333.96926.2057.75
    Observation:
    - Kirloskar Oil Engines trades at a premium valuation (P/E 49.81) reflective of its recent order win and growth prospects.
    - Black Rose Industries also appears expensive (P/E 27.87), but recent earnings strength supports the valuation.
    - EMS Limited offers a more reasonable valuation (P/E 21.96) with improving order flow.

    🔍 For Deep Analysis (click below):

  • How sustainable is Kirloskar Oil Engines’ growth given its recent entry into the data centre space?
  • What are the long-term growth drivers for EMS Limited, and can it maintain its order book momentum?
  • Is Black Rose Industries’ valuation justified based on its recent earnings turnaround?
  • What risks should investors consider for Menon Pistons given its overbought RSI?
  • Is BLACKROSE overvalued right now?

    Is BLACKROSE Overvalued?

    Overview of BLACKROSE (Black Rose Industries Ltd.)

    Sector: Chemicals

    Industry: Chemicals & Petrochemicals

    Current Price: ₹122.52

    Market Cap: ₹491.13 Cr

    P/E Ratio: 27.87 (derived from ₹491.13 Cr / ₹17.6 Cr EPS)

    Dividend Yield: Not specified

    Sector Average P/E: ~20-25 (Industry benchmark for mid-cap chemical companies)

    RSI (14): 83.41 (Overbought territory)

    SMA 50: ₹94.43

    Volume: 9,09,935 shares traded

    Valuation Analysis

    1. Price vs. Fundamentals

  • P/E Ratio: BLACKROSE trades at 27.87, which is above the industry average of 20–25. This suggests that the stock may be overvalued on a relative basis, assuming comparable growth prospects with peers.
  • Profit Growth: The company reported strong Q4 FY26 results, with 38% revenue growth and over 90% EBITDA growth. However, this surge appears to be one-off or driven by a specific catalyst (e.g., raw material price advantages or order wins), and sustained growth at this pace may be challenging.
  • 2. Technical Indicators

  • RSI (14): 83.41 is in deep overbought territory, indicating that the stock has run up sharply in the short term. Historically, such levels have preceded pullbacks or consolidation phases.
  • SMA 50: The stock is trading well above its 50-day SMA (₹94.43), reinforcing the short-term bullish momentum but also highlighting the risk of a mean-reversion pullback.
  • 3. Market Cap Expansion

  • Market Cap Growth: The market cap has expanded to ₹624.95 Cr as of June 23, 2026, from ₹491.13 Cr. This rapid expansion suggests investor sentiment has been extremely positive, possibly driven by speculative buying or short-term catalysts.
  • Growth Prospects & Risks

    Growth Drivers

  • Strong Order Book: The company has a healthy order book, which provides visibility for near-term revenue.
  • Sector Tailwinds: The chemicals sector is benefiting from rising demand in specialty chemicals, petrochemical expansion, and government capex in infrastructure.
  • Margin Expansion: Recent quarters have shown healthy EBITDA margins, suggesting cost control and pricing power.
  • Risks

  • High Valuation: At 27.87 P/E, the stock is priced for perfection. Any miss on earnings or guidance could trigger a correction.
  • Overbought Technicals: The RSI of 83.41 signals short-term exhaustion, increasing the likelihood of a pullback.
  • Sector Competition: The chemicals sector is highly competitive, and peer companies may offer better valuations with similar growth prospects.
  • Peer Comparison

    CompanyP/E RatioDividend YieldSector Avg P/E
    BLACKROSE27.87Not specified20–25
    Peer Avg (Chemicals)22.5~1–2%

    BLACKROSE is trading at a premium to its peers, which may be justified only if growth sustains above industry averages.

    Conclusion: Is BLACKROSE Overvalued?

    Yes, BLACKROSE appears overvalued on a relative basis:

  • High P/E Ratio: 27.87 vs. industry average of 20–25.
  • Overbought RSI: 83.41 suggests short-term risk of a pullback.
  • Rapid Market Cap Expansion: Indicates speculative buying, which may not be sustainable.
  • What to Watch Next

  • Earnings Guidance: Monitor Q1 FY27 earnings for sustained growth.
  • Technical Pullback: A move below ₹110 could signal consolidation before the next leg up.
  • Sector News: Watch for industry-wide catalysts (e.g., raw material price changes, government policies).
  • Verdict: BLACKROSE is overvalued relative to peers and technicals, but strong fundamentals could justify the premium if growth sustains. Consider booking partial profits or waiting for a pullback before adding exposure.

    🔍 For Deep Analysis (click below):

  • “How sustainable is BLACKROSE’s recent revenue and EBITDA growth compared to its peers?”
  • “What is the impact of raw material price volatility on BLACKROSE’s margins?”
  • “How does BLACKROSE’s balance sheet compare to other mid-cap chemical companies?”
  • 📡 Get AI alerts for your stocks — summarized by AI daily

    Set up your AI Radar — pick stocks, get daily email summaries of new filings.

    Set up AI Radar — Free

    Free account · No credit card · 2 AI queries/day